DUBLIN, July 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "NewBorn Screening Market by Test Type, Technology, Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019" report to their offering.
This report studies the newborn screening market by test type, technology, product, and geography.
Newborn screening is a test in which the newborns are screened for a panel of inborn diseases that can lead to disabilities or even death. The newborn testing allows early detection and management of congenital disorders, thereby providing a better life to the affected infant. This market is driven by several factors which include benefits offered by newborn testing programs, legislations and mandates, technological advancements, government support, and the expanding panel of newborn diseases. Government initiatives in the forms of grants and funds have provided an impetus to the market. Technological advancements, which help in introduction of new and innovative devices in the market, are another major factor driving the growth of the market. The relatively untapped Asian market and advent of next-generation sequencing and digital microfluidics technology have opened an array of opportunities for market to grow. However, factors such as lack of trained professional infrastructure and socio-economical barriers may restrain the growth of this market.
The global newborn screening market, estimated at $438.9 million in 2013, is expected to reach $819.6 million by 2019, growing at a CAGR of 11.0% from 2013 to 2019. The market is segmented on the basis of types, technologies, products, and geography.
Based on types, the newborn screening market is segmented into dry blood spot test, hearing screen test, and pulse oximetry test. The dry blood spot test market is slated to grow at the highest CAGR owing to the technological advancements due to which new and advanced products are being launched in the market.
Based on technologies, the market is subdivided into tandem mass spectroscopy, electrophoresis, enzyme and immunoassays, DNA-based assays, hearing screen technology, and pulse oximetry. The tandem mass spectroscopy market is expected to witness the highest growth. This high growth can be attributed to time-effectiveness and cost effectiveness provided by mass spectrometry as compared to the enzyme assays and immunoassays technology. These advantages are the major reasons for the growth of this market.
The newborn screening products market includes instruments, reagents, and assay kits. The instruments market accounts for the largest share of the global products market, followed by reagents and assay kits. The high share of the instruments market can be attributed to the wide usage of newborn screening devices across the globe.
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Newborn Screening Market, By Test Type
6 Newborn Screening Market, By Technology
7 Newborn Screening Market, By Product Type
8 Newborn Screening Market, By Geography
9 Competitive Landscape
10 Company Profiles
- AB Sciex LLC (A Subsidiary of Danaher Corporation)
- Agilent Technologies Inc.
- Bio-Rad Laboratories, Inc.
- Covidien Plc
- GE Healthcare (Subsidiary of General Electric Company)
- Masimo Corporation
- Natus Medical Incorporated
- Perkinelmer, Inc.
- Trivitron Healthcare
- Waters Corporation
For more information visit http://www.researchandmarkets.com/research/zjzvrp/newborn_screening
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets